Nonoxynol-9

Generic Name
Nonoxynol-9
Brand Names
Conceptrol, Gynol II, Today Sponge, Vcf Contraceptive
Drug Type
Small Molecule
Chemical Formula
C33H60O10
CAS Number
26027-38-3
Unique Ingredient Identifier
48Q180SH9T
Background

Nonoxynol-9 (N-9) is a typical surfactant used as a vaginal spermicide. Spermicides are locally acting non-hormonal contraceptives. When present in the vagina during intercourse, they immobilize/inactivate/damage and/or kill sperms without eliciting systemic effects. N-9 has been in use for more than 30 years as an over-the-counter (OTC) drug in creams, gels...

Indication

Nonoxynol 9 is a surfactant spermicide used for contraception in spermicidal creams, jellies, foams, gel, and lubricants. It is also used in conjuction with other methods of contraception, including condoms, cervical caps and diaphragms.

Associated Conditions
-
Associated Therapies
Contraceptive sponge therapy

Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation

First Posted Date
2012-05-07
Last Posted Date
2015-03-31
Lead Sponsor
CONRAD
Target Recruit Count
20
Registration Number
NCT01593124
Locations
🇺🇸

Eastern Virginia Medical School CONRAD Clinical Research Center, Norfolk, Virginia, United States

Study of Contraceptive Efficacy & Safety of Phexxiâ„¢ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel

Phase 3
Completed
Conditions
Interventions
First Posted Date
2011-03-01
Last Posted Date
2022-07-12
Lead Sponsor
Evofem Inc.
Target Recruit Count
3389
Registration Number
NCT01306331
Locations
🇺🇸

Wake Research Associates, Raleigh, North Carolina, United States

🇺🇸

University of Pennsylvania Medical Center, Reproductive Research Unit, Philadelphia, Pennsylvania, United States

🇺🇸

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

and more 48 locations

A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides

First Posted Date
2006-10-18
Last Posted Date
2015-04-01
Lead Sponsor
Johns Hopkins University
Target Recruit Count
12
Registration Number
NCT00389311
Locations
🇺🇸

The Johns Hopkins Hospital, Baltimore, Maryland, United States

A Study of Nonoxynol-9 (N-9) and HIV Infection

Phase 3
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
4400
Registration Number
NCT00000926
Locations
🇺🇸

Julia Welch, Research Triangle Park, North Carolina, United States

A Study of the Effects of Advantage 24 on the Rectum

Phase 1
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
70
Registration Number
NCT00000929
Locations
🇺🇸

Univ of Washington, Seattle, Washington, United States

© Copyright 2024. All Rights Reserved by MedPath